Early detection of cysteine rich protein 61 (CYR61, CCN1) in urine following renal ischemic reperfusion injury

Kidney International

Volumn 62, Issue 5, 2002, Pages 1601-1610

  Muramatsu, Yasunar ^a,b,c   Tsujie, Michiko ^a,b,c   Kohda, Yukimasa ^a,b,c   Pham, Bertha ^a,b,c   Perantoni, Alan O ^a,b,c   Zhao, Hong ^a,b,c   Jo, Sang Kyung ^a,b,c   Yuen, Peter S T ^a,b,c   Craig, Leonard ^a,b,c   Hu, Xuzhen ^a,b,c   Star, Robert A ^a,b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Biomarker; Cyr61; Ischemia; Kidney injury; Reperfusion

Indexed keywords

BINDING PROTEIN; BIOLOGICAL MARKER; CYSTEINE; CYSTEINE RICH PROTEIN 61; GROWTH FACTOR; HEPARIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; GENETIC ANALYSIS; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY INJURY; KIDNEY ISCHEMIA; LIBRARY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION; PROTEIN URINE LEVEL; RAT; REPERFUSION INJURY; RNA ANALYSIS; TIME; UPREGULATION; URINALYSIS; URINARY EXCRETION; WESTERN BLOTTING;

EID: 18644377952     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00633.x     Document Type: Article

References (49)

1. Thadhani R, Pascual M, Bonventre JV: Medical progress-Acute renal failure. N Engl J Med 334:1448-1460, 1996
2. DuBose TD, Jr, Warnock DG, Mehta RL, et al: Acute renal failure in the 21st century: Recommendations for management and outcomes assessment. Am J Kidney Dis 29:793-799, 1997
3. Star RA: Treatment of acute renal failure. Kidney Int 54:1817-1831, 1998
4. Star R: Design issues for clinical trials in acute renal failure. Blood Purif 19:233-237, 2001
5. Conger J: Prophylaxis and treatment of acute renal failure by vasoactive agents: The fact and the myths. Kidney Int 53(Suppl 64):S23-S26, 1998
6. Kelly KJ, Molitoris BA: Acute renal failure in the new millennium: Time to consider combination therapy. Semin Nephrol 20:419, 2000
7. Tepel M, Van der Giet M, Schwarzfeld C, et al: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184, 2000
8. Bellomo R, Chapman M, Finfer S, et al: Low-dose dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356:2139-2143, 2000
9. Allgren RL, Marbury TC, Rahman SN, et al: Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Fail Study Group. N Engl J Med 336:828-834, 1997
10. Liano F, Pascual J, Madrid Acute Renal Failure Study Group: Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Kidney Int 50:811-818, 1996
11. Ouellette AJ, Malt RA, Sukhatme VP, et al: Expression of two "immediate early" genes, Egr-1 and c-fos, in response to renal ischemia and during compensatory renal hypertrophy in mice. J Clin Invest 85:766-771, 1990
12. Emami A, Schwartz JH, Borkan SC: Transient ischemia or heat stress induces a cytoprotectant protein in rat kidney. Am J Physiol (Renal, Fluid Electrolyte Physiol) 260:F479-F485, 1991
13. Lau LF, Nathans D: Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J 4:3145-3151, 1985
14. Latinkic BV, Mo FE, greenspan JA, et al: Promoter function of the angiogenic inducer Cyr61gene in transgenic mice: Tissue specificity, inducibility during wound healing, and role of the serum response element. Endocrinology 142:2549-2557, 2001
15. Grzeszkiewicz TM, Kirschling DJ, Chen N, et al: CYR61 stimulates human skin fibroblast migration through integrin (alpha)V (beta)5 and enhances mitogenesis through integrin (alpha)V(beta)3, independent of its carboxy-terminal domain. J Biol Chem 276: 21943-21950, 2001
16. Wilkinson D, Green J: In situ hybridization and the three-dimensional reconstruction of serial sections, in Postimplantation Mammalian Embroyos, edited by Coop AJ, Cockroft DL, London, Oxford University Press, 1990, pp 155-171
17. McKee JA, Kumar S, Ecelbarger CA, et al: Detection of Na(+) transporter proteins in urine. J Am Soc Nephrol 11:2128-2132, 2000
18. O'Brien TP, Yang GP, Sanders L, et al: Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol 10:3569-3577, 1990
19. Kolesnikova TV, Lau LF: Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells. Oncogene 16:747-754, 1998
20. Sampath D, Zhu Y, Winneker RC, et al: Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas. J Clin Endocrinol Metab 86:1707-1715, 2001
21. Tong X, Xie D, O'Kelly J, et al: Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem 276:47709-47714, 2001
22. Yang GP, Lau LF: Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ 2:351-357, 1991
23. Kireeva ML, Mo FE, Yang GP, et al: Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 16:1326-1334, 1996
24. Sheridan AM, Bonventre JV: Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 9:427-434, 2000
25. Lau LF, Lam SC: The CCN family of angiogenic regulators: The integrin connection. Exp Cell Res 248:44-57, 1999
26. Brigstock DR: The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 20:189-206, 1999
27. Wong M, Kireeva ML, Kolesnikova TV, et al: Cyr61, product of a growth factor-inducible immediate-early gene, regulates chondrogenesis in mouse limb bud mesenchymal cells. Dev Biol 192:492-508, 1997
28. Babic AM, Kireeva ML, Kolesnikova TV, et al: CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 95:6355-6360, 1998
29. Jedsadayanmata A, Chen CC, Kireeva ML, et al: Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha-(IIb)beta(3). J Biol Chem 274:24321-24327, 1999
30. Chen N, Chen CC, Lau LF: Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha6beta1 and cell surface heparan sulfate proteoglycans. J Biol Chem 275:24953-24961, 2000
31. Grzeszkiewicz TM, Lindner V, Chen N, et al: The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through Integrin alpha(6)beta(1) and cell surface heparan sulfate proteoglycans. Endocrinology 143:1441-1450, 2002
32. Tamura I, Rosenbloom J, Macarak E, et al: Regulation of Cyr61 gene expression by mechanical stretch through multiple signaling pathways. Am J Physiol (Cell Physiol) 281:C1524-C1532, 2001
33. Nahm O, Woo SK, Handler JS, et al: Involvement of multiple kinase pathways in stimulation of gene transcription by hypertonicity. Am J Physiol (Cell Physiol) 282:C49-C58, 2002
34. Chen CC, Chen N, Lau LF: The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 276:10443-10452, 2001
35. Chen CC, Mo FE, Lau LF: The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 276:47329-47337, 2001
36. Wu KJ, Yee A, Zhu NL, et al: Characterization of differential gene expression in monkey arterial neointima following balloon catheter injury. Int J Mol Med 6:433-440, 2000
37. Hanjiargyrou M, Ahrens W, Rubin CT: Temporal expression of the chondrogenic and angiogenic growth factor CYR61 during fracture repair. J Bone Miner Res 15:1014-1023, 2000
38. Kireeva ML, Latinkic BV, Kolesnikova TV, et al: Cyr61 and Fisp12 are both ECM-associated signaling molecules: Activities, metabolism, and localization during development. Exp Cell Res 233:63-77, 1997
39. Schutze N, Lechner A, Groll C, et al: The human analog of murine cystein rich protein 61 is a 1alpha,25-dihydroxyvitamin D3 responsive immediate early gene in human fetal osteoblasts: Regulation by cytokines, growth factors, and serum. Endocrinology 139:1761-1770, 1998
40. Leng E, Malcolm T, Tai G, et al: Organization and expression of the cyr61 gene in normal human fibroblasts. J Biomed Sci 9:59-67, 2002
41. Kramer AA, Postler G, Salhab KF, et al: Renal ischemia reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int 55:2362-2367, 1999
42. Daemen MA, Van't Veer C, Denecker G, et al: Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest 104:541-549, 1999
43. Chiao H, Kohda Y, McLeroy P, et al: α-Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99:1165-1172, 1997
44. Miller TR, Anderson R J, Linas SL, et al: Urinary diagnostic indices in acute renal failure: A prospective study. Ann Intern Med 89:47-50, 1978
45. Zarich S, Fang LS, Diamond JR: Fractional excretion of sodium. Exceptions to its diagnostic value. Arch Intern Med 145:108-112, 1985
46. Tolkoff-Rubin NE, Rubin R, Bonventre JV: Noninvasive renal diagnostic studies. Clin Lab Med 8:507-526, 1988
47. Taman M, Liu Y, Tolbert E, et al: Increase urinary hepatocyte growth factor excretion in human acute renal failure. Clin Nephrol 48:241-245, 1997
48. Ichimura T, Bonventre JV, Bailly V, et al: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273:4135-4142, 1998
49. Melnikov VY, Ecder T, Fantuzzi G, et al: Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest 107:1145-1152, 2001